LYMECYCLINE ACTIVO
Lymecycline
What it does
Lymecycline is an antibiotic that helps treat various bacterial infections.
Commonly used for: acne, skin infections, respiratory infections
Read more in plain English ↓Plain-language summary for general understanding - not medical advice. Always follow your pharmacist/doctor.
Ask about this medicine
Answers come only from this medicine's registration record, BNF monograph and interaction data - not medical advice.
Medicine sourcing is available in Kenya only. We don't sell or dispense medicines - licensed pharmacies do.
Sourcing - Kenya onlyRegistration & product details
Source: South African Health Products Regulatory Authority · fetched 2026-04-15 21:29:46 · updated 2026-09-20 04:02:14
Drug Interactions
8Pharmacodynamic Warnings
Lymecycline appears in TABLE 1: Drugs that cause hepatotoxicity
Severe (1)
Tetracyclines - decreases absorption
Strontium is predicted to decrease the absorption of tetracyclines. Avoid. Theoretical Sucralfate
Moderate (3)
Lithium - increases risk of lithium toxicity
Tetracyclines are predicted to increase the risk of lithium toxicity when given with lithium. Avoid or adjust dose.
Tetracyclines - decreases concentration
Fosphenytoin is predicted to decrease the concentration of tetracyclines (doxycycline). Adjust dose.
Tetracyclines - decreases exposure
Rifampicin modestly decreases the exposure to tetracyclines (doxycycline). Adjust dose.
Unknown (4)
Tetracyclines - decreases exposure
Mitotane is predicted to decrease the exposure to tetracyclines (eravacycline). Adjust eravacycline dose, p. 625.
Tetracyclines - decreases exposure
Rifampicin is predicted to decrease the exposure to tetracyclines (eravacycline). Adjust eravacycline dose, p. 625.
Tetracyclines - decreases exposure
St John's wort is predicted to decrease the exposure to tetracyclines (eravacycline). Adjust eravacycline dose, p. 625.
Tetracyclines - decreases absorption
Oralzincispredictedtodecreasetheabsorptionof tetracyclines.Separateadministrationby2to3hours. oTheoretical https://www.facebook.c (Books-Courses-Medic
Data from BNF 85 (British National Formulary). This is not a substitute for professional medical advice. Matched via: class
About this medicine
Lymecycline is an antibiotic that helps treat various bacterial infections.
What it treats
- acne
- skin infections
- respiratory infections
How it works
It works by stopping the growth of bacteria that cause infections.
Who it's for
It is for people with bacterial infections, including teenagers and adults with acne.
Drug class
Tetracyclines
Cautions
- • Avoid using with other drugs that can harm the liver.
AI-assisted summary grounded in BNF data - general information only, not medical advice. Always confirm with your pharmacist or doctor.
Clinical monograph: Lymecycline
BNF-referencedLymecycline is a member of the tetracycline class of antibiotics, which are effective against a broad range of bacterial infections. It works by inhibiting bacterial protein synthesis, making it useful in treating various infections, including those caused by chlamydia, rickettsia, and mycoplasma. It is commonly used in the management of acne vulgaris as an adjunct to topical treatments.
Indications
- Bacterial infections
- Acne vulgaris (adjunct to topical treatment)
- Chlamydia infections
- Rickettsial infections
- Mycoplasma infections
Dosage
Children: For children aged 12–17 years, the recommended dosage is 408 mg once daily. For specific pediatric dosing, refer to the BNF for Children.
Adults: For adults, the typical dosage of Lymecycline is 408 mg once daily, which can be increased to 1.224–1.632 g daily in severe infections.
Mechanism of action
Lymecycline exerts its antibacterial effect by binding to the 30S ribosomal subunit of bacteria, inhibiting the attachment of aminoacyl-tRNA to the mRNA-ribosome complex. This action prevents protein synthesis, which is essential for bacterial growth and reproduction.
Pharmacodynamics
Lymecycline has a broad spectrum of activity against gram-positive and gram-negative bacteria. It is particularly effective against susceptible strains of bacteria responsible for respiratory tract infections, urinary tract infections, and certain sexually transmitted infections. Its efficacy is partly due to its ability to penetrate bacterial cells and accumulate at the site of action.
Pharmacokinetics
Lymecycline is absorbed well from the gastrointestinal tract, with peak plasma concentrations typically occurring 1-2 hours after oral administration. It has a bioavailability of approximately 60-70%. The drug is primarily excreted in the urine, both as unchanged drug and metabolites, with a half-life of about 8-12 hours. Adjustments may be necessary in cases of renal impairment.
Contra-indications
- Hypersensitivity to lymecycline or other tetracyclines
- Severe renal impairment
- Pregnancy (especially during the first trimester)
Adverse effects
- Gastrointestinal discomfort
- Photosensitivity
- Visual impairment
- Skin hyperpigmentation (with long-term use)
- Severe cutaneous adverse reactions (SCARs)
- Tinnitus
Interactions
- Antacids containing aluminum, calcium, or magnesium may reduce absorption
- Iron supplements may also decrease the absorption of lymecycline
- Concurrent use with other nephrotoxic drugs should be approached with caution
Precautions
- Caution in patients with renal impairment
- Monitor for signs of fungal infections, particularly in those predisposed to oral candidiasis
- Avoid excessive sun exposure due to risk of photosensitivity
Pregnancy
Lymecycline is contraindicated during pregnancy, particularly in the first trimester; however, it may be considered if the entire treatment course can be completed before 15 weeks' gestation in unavoidable malaria prophylaxis.
Breast-feeding
Lymecycline should be used with caution during breastfeeding as it may be excreted in breast milk.
Storage
Store in a refrigerator (2–8°C) and protect from light.
Formulations
- Lymecycline 408 mg capsules
AI-synthesized from BNF references - general information only, not a substitute for professional medical advice or the current BNF. Verify doses with a pharmacist.
Molecular reference: Lymecycline
PubChem CID 54707177Molecular formula: C29H38N4O10
Biological pathways
Source: PubChem (NCBI) · pathways from PathBank, Reactome, WikiPathways & PharmGKB.
This drug in other countries
The same active ingredient registered across other registries we cover - including different brands.